Chronic Granulomatous Disease: The European Experience
Top Cited Papers
Open Access
- 21 April 2009
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 4 (4) , e5234
- https://doi.org/10.1371/journal.pone.0005234
Abstract
CGD is an immunodeficiency caused by deletions or mutations in genes that encode subunits of the leukocyte NADPH oxidase complex. Normally, assembly of the NADPH oxidase complex in phagosomes of certain phagocytic cells leads to a “respiratory burst”, essential for the clearance of phagocytosed micro-organisms. CGD patients lack this mechanism, which leads to life-threatening infections and granuloma formation. However, a clear picture of the clinical course of CGD is hampered by its low prevalence (∼1∶250,000). Therefore, extensive clinical data from 429 European patients were collected and analyzed. Of these patients 351 were males and 78 were females. X-linked (XL) CGD (gp91phox deficient) accounted for 67% of the cases, autosomal recessive (AR) inheritance for 33%. AR-CGD was diagnosed later in life, and the mean survival time was significantly better in AR patients (49.6 years) than in XL CGD (37.8 years), suggesting a milder disease course in AR patients. The disease manifested itself most frequently in the lungs (66% of patients), skin (53%), lymph nodes (50%), gastrointestinal tract (48%) and liver (32%). The most frequently cultured micro-organisms per episode were Staphylococcus aureus (30%), Aspergillus spp. (26%), and Salmonella spp. (16%). Surprisingly, Pseudomonas spp. (2%) and Burkholderia cepacia (<1%) were found only sporadically. Lesions induced by inoculation with BCG occurred in 8% of the patients. Only 71% of the patients received antibiotic maintenance therapy, and 53% antifungal prophylaxis. 33% were treated with γ-interferon. 24 patients (6%) had received a stem cell transplantation. The most prominent reason of death was pneumonia and pulmonary abscess (18/84 cases), septicemia (16/84) and brain abscess (4/84). These data provide further insight in the clinical course of CGD in Europe and hopefully can help to increase awareness and optimize the treatment of these patients.Keywords
This publication has 39 references indexed in Scilit:
- Special Article: Chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient-based registryClinical and Experimental Immunology, 2008
- Susceptibility to Mycobacterial Infections in Children With X-Linked Chronic Granulomatous DiseaseThe Pediatric Infectious Disease Journal, 2008
- Chronic Granulomatous Disease (CGD) and Complete Myeloperoxidase Deficiency Both Yield Strongly Reduced Dihydrorhodamine 123 Test Signals but Can Be Easily Discerned in Routine Testing for CGDClinical Chemistry, 2007
- Cutaneous and other lupus-like symptoms in carriers of X-linked chronic granulomatous disease: incidence and autoimmune serologyClinical and Experimental Immunology, 2007
- Successful treatment of Paecilomyces variotii splenic abscesses: a rare complication in a previously unrecognized chronic granulomatous disease childDiagnostic Microbiology and Infectious Disease, 2005
- Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantationBone Marrow Transplantation, 2000
- Recombinant human interferon-gamma in patients with chronic granulomatous disease —European follow up studyEuropean Journal of Pediatrics, 1995
- Polyarthritis resembling juvenile rheumatoid arthritis in a girl with chronic granulomatous diseaseArthritis & Rheumatism, 1994
- Systemic lupus erythematosus in a boy with chronic granulomatous disease: Case report and review of the literatureArthritis & Rheumatism, 1991
- Urinary Tract Disorders in Patients with Chronic Granulomatous DiseaseNew England Journal of Medicine, 1989